Presentazione di PowerPoint

1
PET E TUMORI NEUROENDOCRINI NUOVI TRACCIANTI
Stefano Fanti
2
(No Transcript)
3
18F-DOPA PET
Somatostatin Receptor PET
4
18F-DOPA PET
5
CLINICAL APPLICATIONS
NEUROLOGY Movement disorders (Parkinson Disease)
ONCOLOGY Neuroendocrine tumors Pheochromocytoma N
euroblastoma (?)
6
(No Transcript)
7
F-DOPA
FDG
M, 59yo. Metastatic carcinoid.
8
F 45yo staging of metastatic carcinoid. Several
bone lesions
9
Male,62yo. Secondary lesions within the liver.
Unknown primary.
10
Male,58yo. Ileum NET already operated (2004).
Restaging
11
(No Transcript)
12
(No Transcript)
13
Female,30yo. Diffuse secondary lesions within the
liver. Unknown primary.
14
Male,52yo. Secondary lesions within the liver.
Unknown primary.
15
Somatostatin Receptor PET
16
Somatostatin Receptor PET
17
Somatostatin Receptor PET
18
Somatostatin Receptor PET
19
Somatostatin Receptor PET
20
68Gallium
21
DOTA-WHAT ?
22
Somatostatin Receptor PET